Skip to main content
Aytu BioPharma, Inc. (AYTU)
NASDAQ: AYTU · Real-Time Price · USD
2.220
-0.020 (-0.89%)
At close: Dec 5, 2025, 4:00 PM EST
2.250
+0.030 (1.35%)
After-hours: Dec 5, 2025, 5:15 PM EST

Aytu BioPharma Revenue

Aytu BioPharma had revenue of $13.89M in the quarter ending September 30, 2025, a decrease of -16.21%. This brings the company's revenue in the last twelve months to $63.70M, down -0.38% year-over-year. In the fiscal year ending June 30, 2025, Aytu BioPharma had annual revenue of $66.38M with 1.84% growth.

Revenue (ttm)
$63.70M
Revenue Growth
-0.38%
P/S Ratio
0.25
Revenue / Employee
$767,422
Employees
83
Market Cap
22.62M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Jun 30, 202566.38M1.20M1.84%
Jun 30, 202465.18M-8.62M-11.67%
Jun 30, 202373.80M-22.87M-23.66%
Jun 30, 202296.67M31.04M47.29%
Jun 30, 202165.63M38.00M137.52%
Jun 30, 2020 Pro Pro Pro
Jun 30, 2019 Pro Pro Pro
Jun 30, 2018 Pro Pro Pro
Jun 30, 2017 Pro Pro Pro
Jun 30, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
UnitedHealth Group 435.16B
Johnson & Johnson 92.15B
Merck & Co. 64.24B
AbbVie 59.64B
Eli Lilly and Company 59.42B
AstraZeneca 58.13B
Novartis AG 56.37B
Novo Nordisk 49.58B
Revenue Rankings

AYTU News

More News